(MO) Altria - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US02209S1033

MO: Cigarettes, Cigars, Oral Tobacco, Nicotine Pouches, E-Vapor Products

Altria Group, Inc. (NYSE:MO) is a leading U.S. tobacco company with a diversified portfolio of smokeable and oral tobacco products. Its flagship Marlboro brand dominates the cigarette market, while Black & Mild large cigars and pipe tobacco cater to premium cigar enthusiasts. The company also holds a strong position in moist smokeless tobacco with brands like Copenhagen and Skoal, offering a range of flavors and nicotine levels. In addition, Altria markets oral nicotine pouches under the on! brand and e-vapor products through NJOY ACE, addressing evolving consumer preferences. Its products are distributed to wholesalers, retailers, and major chain stores across the United States. Established in 1822 and headquartered in Richmond, Virginia, Altria operates as a holding company with a focus on innovation and regulatory compliance in the tobacco industry.

From a technical perspective, MO is currently trading at 58.16 with a 20-day average volume of 12.1 million shares. The stock is below its 50-day SMA (55.82) and 200-day SMA (51.38), indicating bearish momentum. Support levels are clustered between 43.1 and 58.0, with key resistance potentially forming near the 200-day SMA. The ATR of 1.40 suggests moderate volatility. On the fundamental side, Altrias market cap stands at 95.53 billion USD, with a trailing P/E of 8.66 and a forward P/E of 10.62, signaling expectations of earnings growth. The P/B ratio of 27.30 reflects a premium valuation relative to book value, while the P/S ratio of 4.67 indicates a strong revenue multiple.

3-month forecast: Based on and , MO is expected to face resistance at its 200-day SMA (51.38) and potentially retest support at 56.5. If the stock maintains above 56.5, it could attempt a rally toward 62.0. However, failure to hold above 56.5 may lead to a decline toward 48.1. Fundamentally, while the trailing P/E of 8.66 suggests undervaluation, the declining operating margins and regulatory headwinds may limit upside potential in the near term.

Additional Sources for MO Stock

MO Stock Overview

Market Cap in USD 98,886m
Sector Consumer Defensive
Industry Tobacco
GiC Sub-Industry Tobacco
IPO / Inception 1970-01-02

MO Stock Ratings

Growth Rating 84.8
Fundamental 53.8
Dividend Rating 86.4
Rel. Strength 31.3
Analysts 3.29/5
Fair Price Momentum 69.96 USD
Fair Price DCF 112.23 USD

MO Dividends

Dividend Yield 12m 7.38%
Yield on Cost 5y 15.84%
Annual Growth 5y 3.30%
Payout Consistency 98.1%

MO Growth Ratios

Growth Correlation 3m 84.7%
Growth Correlation 12m 92.7%
Growth Correlation 5y 83.3%
CAGR 5y 18.33%
CAGR/Max DD 5y 0.71
Sharpe Ratio 12m 1.53
Alpha 41.16
Beta 0.079
Volatility 19.67%
Current Volume 12873.1k
Average Volume 20d 11049.1k
What is the price of MO stocks?
As of May 01, 2025, the stock is trading at USD 59.15 with a total of 12,873,053 shares traded.
Over the past week, the price has changed by +0.56%, over one month by +1.72%, over three months by +16.83% and over the past year by +45.97%.
Is Altria a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Altria (NYSE:MO) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 53.78 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MO as of May 2025 is 69.96. This means that MO is currently undervalued and has a potential upside of +18.28% (Margin of Safety).
Is MO a buy, sell or hold?
Altria has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold MO.
  • Strong Buy: 3
  • Buy: 1
  • Hold: 8
  • Sell: 1
  • Strong Sell: 1
What are the forecast for MO stock price target?
According to ValueRays Forecast Model, MO Altria will be worth about 75.6 in May 2026. The stock is currently trading at 59.15. This means that the stock has a potential upside of +27.74%.
Issuer Forecast Upside
Wallstreet Target Price 57.4 -3%
Analysts Target Price 57.1 -3.4%
ValueRay Target Price 75.6 27.7%